zoledronic acid has been researched along with Insulin Resistance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giagourta, I; Karga, H; Kassi, G; Ktena, V; Papaioannou, G; Papamichael, K; Papandroulaki, F; Thanou, S; Triantaphyllopoulou, M; Zapanti, E | 1 |
| Anastasilakis, AD; Bisbinas, I; Delaroudis, S; Gerou, S; Gkiomisi, A; Makras, P; Papadopoulou, E; Polyzos, SA; Sakellariou, GT | 1 |
2 other study(ies) available for zoledronic acid and Insulin Resistance
| Article | Year |
|---|---|
Cytokines and insulin resistance after zoledronic acid-induced acute phase response.
Topics: Acute-Phase Reaction; Adiponectin; Bone Density Conservation Agents; C-Reactive Protein; Diphosphonates; Female; Humans; Hydrocortisone; Imidazoles; Insulin Resistance; Interleukin-6; Leptin; Middle Aged; Osteoporosis, Postmenopausal; Resistin; Tumor Necrosis Factor-alpha; Zoledronic Acid | 2014 |
The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.
Topics: Acute-Phase Reaction; Adipokines; Age Factors; Aged; Bone Density; Bone Density Conservation Agents; Cytokines; Diphosphonates; Female; Humans; Imidazoles; Insulin Resistance; Lymphocyte Count; Middle Aged; Nicotinamide Phosphoribosyltransferase; Osteoporosis, Postmenopausal; Postmenopause; Risk Factors; Zoledronic Acid | 2012 |